Bristol Myers Squibb - 52 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of May 28, 2024 is 40.49.
  • The all-time high Bristol Myers Squibb stock closing price was 75.88 on December 02, 2022.
  • The Bristol Myers Squibb 52-week high stock price is 66.46, which is 64.1% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 40.38, which is 0.3% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 54.40.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 48.7591 51.5568 53.7723 40.4900 40.4900 -19.25%
2023 60.1323 67.5873 70.2630 47.3744 50.1399 -25.49%
2022 67.3774 56.1253 75.8837 56.1253 67.2973 19.00%
2021 56.4633 54.3889 62.3480 48.6425 56.5516 2.89%
2020 52.7239 54.4092 57.9225 39.8577 54.9649 0.39%
2019 42.2802 43.1902 54.7503 36.1809 54.7503 27.86%
2018 47.1048 49.1907 55.7031 40.1670 42.8195 -12.91%
2017 45.7429 46.4331 52.4321 36.8097 49.1667 7.72%
2016 48.8882 51.4156 59.5478 38.4508 45.6443 -13.50%
2015 48.8047 44.6122 53.9435 43.4417 52.7656 19.24%
2014 38.4940 38.1135 45.6696 34.2089 44.2524 14.18%
2013 31.4236 23.1324 38.9942 23.1324 38.7552 69.95%
2012 22.9490 23.5454 25.0408 21.5581 22.8036 -3.78%
2011 19.1614 17.0623 23.7337 16.2317 23.7001 39.43%
2010 16.1772 15.8666 17.7217 14.0579 16.9981 8.74%
2009 13.0168 13.9879 15.8725 10.2566 15.6313 14.78%
2008 12.2334 14.4517 14.9771 9.9749 13.6188 -6.05%
2007 15.5321 14.0171 17.4034 13.8684 14.4955 4.75%
2006 12.4704 11.6697 13.8384 10.5220 13.8384 19.93%
2005 11.9532 12.2052 12.9936 10.5600 11.5392 -6.16%
2004 11.8625 13.6086 14.2068 10.6737 12.2964 -7.27%
2003 11.4121 10.6685 13.2609 9.3810 13.2609 29.02%
2002 13.3112 21.6285 21.8199 8.9067 10.2778 -52.36%
2001 24.0713 29.6788 29.6788 20.7274 21.5735 -29.71%
2000 24.0009 26.3107 30.6917 17.8348 30.6917 17.11%
1999 27.6863 26.2795 31.8227 23.3048 26.2086 -2.80%
1998 21.7826 18.8658 26.9647 17.9049 26.9647 42.93%
1997 15.0407 10.4688 19.4202 10.4688 18.8658 77.07%
1996 8.8313 8.0388 11.2360 7.6185 10.6546 32.15%
1995 6.3751 5.3622 8.0858 5.2831 8.0623 53.26%
1994 4.9216 4.9565 5.4408 4.4257 5.2604 6.09%
1993 4.8847 5.4449 5.4449 4.2981 4.9582 -9.48%
1992 5.7375 6.9476 6.9870 4.9940 5.4774 -21.16%
1991 6.1303 5.0865 6.9476 4.6857 6.9476 35.84%
1990 4.4135 4.1797 5.1259 3.7561 5.1147 24.55%
1989 3.5544 3.1252 4.1500 3.0984 4.1064 28.87%
1988 2.9675 3.0123 3.2039 2.6815 3.1864 9.89%
1987 3.3219 2.9381 3.8307 2.5422 2.8995 0.78%
1986 2.6358 2.2897 3.0600 2.1027 2.8772 24.71%
1985 2.0410 1.7848 2.3548 1.7325 2.3071 26.48%
1984 1.6155 1.5020 1.8283 1.4539 1.8241 23.98%
1983 1.3521 1.1666 1.6587 1.0970 1.4713 25.64%
1982 1.0349 0.9185 1.2754 0.8903 1.1710 26.58%
1981 0.9115 0.8880 1.0186 0.8032 0.9251 5.46%
1980 0.7089 0.6335 0.8946 0.5354 0.8772 36.15%
1979 0.6016 0.6202 0.6660 0.5441 0.6443 3.50%
1978 0.5864 0.5812 0.6921 0.4919 0.6225 6.30%
1977 0.5672 0.5920 0.6202 0.5028 0.5856 -1.99%
1976 0.6365 0.6029 0.7204 0.5386 0.5975 -0.35%
1975 0.5406 0.4451 0.6409 0.4102 0.5996 37.40%
1974 0.4045 0.4070 0.4887 0.2753 0.4364 8.10%
1973 0.5324 0.5964 0.6214 0.3831 0.4037 -32.80%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $83.598B $45.006B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $164.063B 16.42
Vertex Pharmaceuticals (VRTX) United States $117.918B 30.34
Regeneron Pharmaceuticals (REGN) United States $108.535B 26.54
GSK (GSK) United Kingdom $93.508B 11.17
CSL (CSLLY) Australia $90.339B 0.00
Gilead Sciences (GILD) United States $81.828B 16.30
Moderna (MRNA) United States $63.852B 0.00
Biogen (BIIB) United States $31.712B 14.52
BioNTech SE (BNTX) Germany $23.048B 193.90
Argenex SE (ARGX) Netherlands $21.815B 0.00
Alnylam Pharmaceuticals (ALNY) United States $18.690B 0.00
Genmab (GMAB) Denmark $18.514B 21.70
Illumina (ILMN) United States $16.962B 121.00
BeiGene (BGNE) Cayman Islands $14.612B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.340B 55.94
Incyte (INCY) United States $12.868B 19.90
Bio-Techne Corp (TECH) United States $12.731B 48.09
Sarepta Therapeutics (SRPT) United States $11.670B 1028.83
QIAGEN (QGEN) Netherlands $9.979B 21.32
Exact Sciences (EXAS) United States $9.197B 0.00
Roivant Sciences (ROIV) United Kingdom $8.848B 0.00
Repligen (RGEN) United States $8.837B 115.44
Bio-Rad Laboratories (BIO.B) United States $7.984B 26.11
Ascendis Pharma (ASND) Denmark $7.593B 0.00
Legend Biotech (LEGN) United States $7.548B 0.00
Vaxcyte (PCVX) United States $7.481B 0.00
Intra-Cellular Therapies (ITCI) United States $6.919B 0.00
Viking Therapeutics (VKTX) United States $6.919B 0.00
Blueprint Medicines (BPMC) United States $6.438B 0.00
Exelixis (EXEL) United States $6.237B 32.14
Halozyme Therapeutics (HALO) United States $5.577B 15.48
Cytokinetics (CYTK) United States $5.064B 0.00
Apellis Pharmaceuticals (APLS) United States $4.929B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.691B 0.00
Krystal Biotech (KRYS) United States $4.650B 0.00
ImmunityBio (IBRX) United States $4.509B 0.00
Nuvalent (NUVL) United States $4.387B 0.00
Zealand Pharma (ZLDPF) Denmark $4.340B 0.00
Immunovant (IMVT) United States $4.206B 0.00
Alkermes (ALKS) Ireland $4.065B 15.91
Axsome Therapeutics (AXSM) United States $3.571B 0.00
Merus (MRUS) Netherlands $3.521B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.354B 0.00
Insmed (INSM) United States $3.269B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.264B 0.00
Biohaven (BHVN) United States $3.242B 0.00
SpringWorks Therapeutics (SWTX) United States $3.140B 0.00
Guardant Health (GH) United States $3.123B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.896B 0.00
Amicus Therapeutics (FOLD) United States $2.861B 0.00
IDEAYA Biosciences (IDYA) United States $2.854B 0.00
Apogee Therapeutics (APGE) United States $2.808B 0.00
Iovance Biotherapeutics (IOVA) United States $2.801B 0.00
MorphoSys AG (MOR) Germany $2.793B 0.00
Arcellx (ACLX) United States $2.777B 0.00
Denali Therapeutics (DNLI) United States $2.740B 0.00
Certara (CERT) United States $2.691B 61.96
Avidity Biosciences (RNA) United States $2.625B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.610B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.511B 0.00
Twist Bioscience (TWST) United States $2.459B 0.00
Celldex Therapeutics (CLDX) United States $2.433B 0.00
Arvinas (ARVN) United States $2.411B 0.00
Intellia Therapeutics (NTLA) United States $2.396B 0.00
Janux Therapeutics (JANX) United States $2.352B 0.00
Vericel (VCEL) United States $2.344B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.303B 0.00
Fortrea Holdings (FTRE) United States $2.284B 28.08
Rhythm Pharmaceuticals (RYTM) United States $2.241B 0.00
ADMA Biologics Inc (ADMA) United States $2.216B 86.91
Deciphera Pharmaceuticals (DCPH) United States $2.206B 0.00
CG Oncology (CGON) United States $2.180B 0.00
Novavax (NVAX) United States $2.176B 0.00
Myriad Genetics (MYGN) United States $2.096B 0.00
Kymera Therapeutics (KYMR) United States $2.089B 0.00
Geron (GERN) United States $2.064B 0.00
Vera Therapeutics (VERA) United States $2.030B 0.00
Bavarian Nordic (BVNRY) Denmark $2.028B 8.83
Beam Therapeutics (BEAM) United States $2.002B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.945B 0.00
NeoGenomics (NEO) United States $1.819B 0.00
Galapagos (GLPG) Belgium $1.797B 0.00
Inhibrx (INBX) United States $1.789B 0.00
Protagonist Therapeutics (PTGX) United States $1.784B 12.46
Zai Lab (ZLAB) China $1.778B 0.00
Sana Biotechnology (SANA) United States $1.776B 0.00
Keros Therapeutics (KROS) United States $1.749B 0.00
Structure Therapeutics (GPCR) United States $1.728B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.724B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.701B 12.97
Kura Oncology (KURA) United States $1.613B 0.00
Edgewise Therapeutics (EWTX) United States $1.598B 0.00
Ligand Pharmaceuticals (LGND) United States $1.555B 25.41
Morphic Holding (MORF) United States $1.543B 0.00
Dynavax Technologies (DVAX) United States $1.491B 189.83
Arcus Biosciences (RCUS) United States $1.466B 0.00
Neumora Therapeutics (NMRA) United States $1.463B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.462B 0.00
Vir Biotechnology (VIR) United States $1.435B 0.00
Cullinan Therapeutics (CGEM) United States $1.391B 0.00
Belite Bio (BLTE) United States $1.358B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.351B 0.00
Spyre Therapeutics (SYRE) United States $1.329B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.323B 0.00
MannKind (MNKD) United States $1.302B 159.33
ANI Pharmaceuticals (ANIP) United States $1.286B 15.97
Akero Therapeutics (AKRO) United States $1.267B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.203B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.157B 0.00
MiMedx (MDXG) United States $1.144B 48.44
AbCellera Biologics (ABCL) Canada $1.132B 0.00
Prothena (PRTA) Ireland $1.078B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.060B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.042B 0.00
Gyre Therapeutics (GYRE) United States $1.025B 0.00
Immatics (IMTX) Germany $0.991B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.985B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.973B 0.00
Liquidia Technologies (LQDA) United States $0.949B 0.00
Mesoblast (MESO) Australia $0.933B 0.00
Tyra Biosciences (TYRA) United States $0.910B 0.00
Abivax SA (ABVX) France $0.872B 0.00
Immunome (IMNM) United States $0.853B 0.00
Humacyte (HUMA) United States $0.851B 0.00
Scholar Rock Holding (SRRK) United States $0.851B 0.00
Disc Medicine (IRON) United States $0.847B 0.00
Prime Medicine (PRME) United States $0.831B 0.00
CureVac (CVAC) Germany $0.826B 0.00
CARGO Therapeutics (CRGX) United States $0.821B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.819B 0.00
89BIO (ETNB) United States $0.801B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.800B 0.00
PureTech Health (PRTC) United States $0.791B 0.00
Cogent Biosciences (COGT) United States $0.786B 0.00
Cytek Biosciences (CTKB) United States $0.782B 0.00
Viridian Therapeutics (VRDN) United States $0.773B 0.00
Pliant Therapeutics (PLRX) United States $0.768B 0.00
WAVE Life Sciences (WVE) Singapore $0.762B 0.00
Nuvation Bio (NUVB) United States $0.761B 0.00
Praxis Precision Medicines (PRAX) United States $0.754B 0.00
Stoke Therapeutics (STOK) United States $0.751B 0.00
Nurix Therapeutics (NRIX) United States $0.746B 0.00
Tango Therapeutics (TNGX) United States $0.738B 0.00
REGENXBIO (RGNX) United States $0.735B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.731B 0.00
GH Research (GHRS) Ireland $0.713B 0.00
ALX Oncology Holdings (ALXO) United States $0.686B 0.00
Castle Biosciences (CSTL) United States $0.673B 0.00
Dianthus Therapeutics (DNTH) United States $0.662B 0.00
AnaptysBio (ANAB) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
ArriVent BioPharma (AVBP) United States $0.644B 0.00
HilleVax (HLVX) United States $0.641B 0.00
ITeos Therapeutics (ITOS) United States $0.639B 0.00
Pharming Group (PHAR) Netherlands $0.627B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
Arbutus Biopharma (ABUS) United States $0.621B 0.00
Zymeworks (ZYME) United States $0.617B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.615B 0.00
Mineralys Therapeutics (MLYS) United States $0.606B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.581B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.578B 0.00
Oric Pharmaceuticals (ORIC) United States $0.576B 0.00
Third Harmonic Bio (THRD) United States $0.573B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
IGM Biosciences (IGMS) United States $0.564B 0.00
Kyverna Therapeutics (KYTX) United States $0.561B 0.00
EnGene Holdings (ENGN) United States $0.560B 0.00
Avid Bioservices (CDMO) United States $0.555B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.536B 0.00
Northwest Biotherapeutics (NWBO) United States $0.533B 0.00
Cabaletta Bio (CABA) United States $0.527B 0.00
Entrada Therapeutics (TRDA) United States $0.511B 24.02
Adaptive Biotechnologies (ADPT) United States $0.507B 0.00
Olema Pharmaceuticals (OLMA) United States $0.507B 0.00
Astria Therapeutics (ATXS) United States $0.495B 0.00
Aerovate Therapeutics (AVTE) United States $0.492B 0.00
Celcuity (CELC) United States $0.488B 0.00
Alector (ALEC) United States $0.481B 0.00
Oculis Holding AG (OCS) Switzerland $0.480B 0.00
Absci (ABSI) United States $0.476B 0.00
MaxCyte (MXCT) United States $0.475B 0.00
PepGen (PEPG) United States $0.472B 0.00
Travere Therapeutics (TVTX) United States $0.469B 0.00
Applied Therapeutics (APLT) United States $0.466B 0.00
Editas Medicine (EDIT) United States $0.463B 0.00
Annexon (ANNX) United States $0.458B 0.00
Erasca (ERAS) United States $0.456B 0.00
Ocugen (OCGN) United States $0.450B 0.00
Fulcrum Therapeutics (FULC) United States $0.448B 0.00
Voyager Therapeutics (VYGR) United States $0.448B 0.00
TScan Therapeutics (TCRX) United States $0.445B 0.00
Allogene Therapeutics (ALLO) United States $0.431B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.424B 0.00
Neurogene (NGNE) United States $0.417B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.414B 0.00
ACELYRIN, INC (SLRN) United States $0.409B 0.00
Contineum Therapeutics (CTNM) United States $0.405B 0.00
Fate Therapeutics (FATE) United States $0.401B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.399B 0.00
Biomea Fusion (BMEA) United States $0.395B 0.00
Terns Pharmaceuticals (TERN) United States $0.388B 0.00
Adlai Nortye (ANL) Cayman Islands $0.387B 0.00
C4 Therapeutics (CCCC) United States $0.377B 0.00
FibroBiologics (FBLG) United States $0.376B 0.00
Anika Therapeutics (ANIK) United States $0.364B 307.12
Jasper Therapeutics (JSPR) United States $0.360B 0.00
Tenaya Therapeutics (TNYA) United States $0.356B 0.00
Shattuck Labs (STTK) United States $0.356B 0.00
AC Immune (ACIU) Switzerland $0.350B 0.00
Aura Biosciences (AURA) United States $0.348B 0.00
Amarin (AMRN) Ireland $0.348B 0.00
Alto Neuroscience (ANRO) United States $0.347B 0.00
Precigen (PGEN) United States $0.343B 0.00
MeiraGTx Holdings (MGTX) United States $0.340B 0.00
Sutro Biopharma (STRO) United States $0.339B 0.00
Anavex Life Sciences (AVXL) United States $0.339B 0.00
Skye Bioscience (SKYE) United States $0.339B 0.00
Nautilus Biotechnology (NAUT) United States $0.337B 0.00
Replimune (REPL) United States $0.321B 0.00
Nkarta (NKTX) United States $0.318B 0.00
Urogen Pharma (URGN) United States $0.311B 0.00
Q32 Bio (QTTB) United States $0.310B 0.00
Atea Pharmaceuticals (AVIR) United States $0.308B 0.00
Ventyx Biosciences (VTYX) United States $0.308B 0.00
Kamada (KMDA) Israel $0.305B 23.04
ADC Therapeutics SA (ADCT) Switzerland $0.305B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.304B 0.00
Solid Biosciences (SLDB) United States $0.299B 0.00
Mersana Therapeutics (MRSN) United States $0.291B 0.00
XOMA (XOMA) United States $0.290B 0.00
Poseida Therapeutics (PSTX) United States $0.288B 0.00
Agenus (AGEN) United States $0.286B 0.00
Inovio Pharmaceuticals (INO) United States $0.285B 0.00
Revance Therapeutics (RVNC) United States $0.283B 0.00
Inozyme Pharma (INZY) United States $0.283B 0.00
CorMedix Inc (CRMD) United States $0.281B 0.00
Caribou Biosciences (CRBU) United States $0.268B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.259B 0.00
XBiotech (XBIT) United States $0.253B 0.00
Boundless Bio (BOLD) United States $0.252B 0.00
Prima BioMed (IMMP) Australia $0.250B 0.00
Emergent Biosolutions (EBS) United States $0.249B 0.00
23andMe Holding (ME) United States $0.248B 0.00
Design Therapeutics (DSGN) United States $0.246B 0.00
Zura Bio (ZURA) United States $0.239B 0.00
ChromaDex (CDXC) United States $0.236B 0.00
Innate Pharma S.A (IPHA) France $0.235B 0.00
Candel Therapeutics (CADL) United States $0.232B 0.00
2seventy Bio (TSVT) United States $0.232B 0.00
UniQure (QURE) Netherlands $0.231B 0.00
Invivyd (IVVD) United States $0.230B 0.00
GENFIT S.A (GNFT) France $0.226B 0.00
Rani Therapeutics Holdings (RANI) United States $0.224B 0.00
Codexis (CDXS) United States $0.224B 0.00
Coherus BioSciences (CHRS) United States $0.219B 0.00
G1 Therapeutics (GTHX) United States $0.214B 0.00
Ovid Therapeutics (OVID) United States $0.213B 0.00
Werewolf Therapeutics (HOWL) United States $0.212B 0.00
Compugen (CGEN) Israel $0.211B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.210B 0.00
Elevation Oncology (ELEV) United States $0.210B 0.00
Renovaro (RENB) United States $0.209B 0.00
Scilex Holding (SCLX) United States $0.205B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.204B 0.00
Compass Therapeutics (CMPX) United States $0.202B 0.00
INmune Bio (INMB) United States $0.200B 0.00
Puma Biotechnology (PBYI) United States $0.193B 12.12
Orchestra BioMed Holdings (OBIO) United States $0.190B 0.00
Opthea (OPT) Australia $0.187B 0.00
Oncobiologics (OTLK) United States $0.185B 0.00
Inventiva S.A (IVA) France $0.182B 0.00
Trevi Therapeutics (TRVI) United States $0.176B 0.00
Greenwich LifeSciences (GLSI) United States $0.173B 0.00
Lifecore Biomedical (LFCR) United States $0.170B 0.00
Abeona Therapeutics (ABEO) United States $0.167B 0.00
Kodiak Sciences (KOD) United States $0.161B 0.00
Adverum Biotechnologies (ADVM) United States $0.158B 0.00
Cellectis S.A (CLLS) France $0.157B 0.00
Alimera Sciences (ALIM) United States $0.155B 0.00
Cardiff Oncology (CRDF) United States $0.154B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.153B 0.00
X4 Pharmaceuticals (XFOR) United States $0.152B 0.00
Sagimet Biosciences (SGMT) United States $0.147B 0.00
Rapt Therapeutics (RAPT) United States $0.146B 0.00
TELA Bio (TELA) United States $0.144B 0.00
Rezolute (RZLT) United States $0.143B 0.00
I-Mab (IMAB) China $0.142B 0.00
Gossamer Bio (GOSS) United States $0.140B 0.00
Seres Therapeutics (MCRB) United States $0.139B 0.00
Molecular Partners AG (MOLN) Switzerland $0.138B 0.00
Vigil Neuroscience (VIGL) United States $0.136B 0.00
CytomX Therapeutics (CTMX) United States $0.136B 8.75
Syros Pharmaceuticals (SYRS) United States $0.133B 0.00
Repare Therapeutics (RPTX) Canada $0.132B 0.00
Cartesian Therapeutics (RNAC) United States $0.131B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.129B 0.00
ScPharmaceuticals (SCPH) United States $0.127B 0.00
Allakos (ALLK) United States $0.126B 0.00
Seer (SEER) United States $0.126B 0.00
ATyr Pharma (LIFE) United States $0.124B 0.00
Sangamo Therapeutics (SGMO) United States $0.124B 0.00
Adicet Bio (ACET) United States $0.122B 0.00
BioStem Technologies (BSEM) $0.121B 0.00
DBV Technologies S.A (DBVT) France $0.118B 0.00
Omega Therapeutics (OMGA) United States $0.117B 0.00
BeyondSpring (BYSI) United States $0.116B 0.00
Coya Therapeutics (COYA) United States $0.116B 0.00
CervoMed (CRVO) United States $0.115B 0.00
Nuvectis Pharma (NVCT) United States $0.114B 0.00
Adagene (ADAG) China $0.114B 0.00
PDS Biotechnology (PDSB) United States $0.113B 0.00
Immunic (IMUX) United States $0.113B 0.00
VistaGen Therapeutics (VTGN) United States $0.110B 0.00
DiaMedica Therapeutics (DMAC) United States $0.109B 0.00
Vor Biopharma (VOR) $0.106B 0.00
Bluebird Bio (BLUE) United States $0.106B 0.00
Verastem (VSTM) United States $0.104B 0.00
Cognition Therapeutics (CGTX) United States $0.102B 0.00
BioHarvest Sciences (CNVCF) Canada $0.101B 0.00
Athira Pharma (ATHA) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.101B 0.00
Akoya Biosciences (AKYA) United States $0.097B 0.00
Connect Biopharma Holdings (CNTB) United States $0.097B 0.00
YS Biopharma (YS) China $0.095B 0.00
Eton Pharmaceuticals (ETON) United States $0.092B 89.50
Milestone Pharmaceuticals (MIST) Canada $0.091B 0.00
Precision BioSciences (DTIL) United States $0.088B 0.00
Gritstone Bio (GRTS) United States $0.087B 0.00
Elicio Therapeutics (ELTX) United States $0.086B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.086B 0.00
InflaRx (IFRX) Germany $0.085B 0.00
Benitec Biopharma (BNTC) United States $0.085B 0.00
IO Biotech (IOBT) Denmark $0.084B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.083B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
Oncolytics Biotech (ONCY) Canada $0.083B 0.00
BioAtla (BCAB) United States $0.082B 0.00
Annovis Bio (ANVS) United States $0.081B 0.00
Galena Biopharma (SLS) United States $0.081B 0.00
Spero Therapeutics (SPRO) United States $0.079B 2.88
HOOKIPA Pharma (HOOK) United States $0.079B 0.00
Cue Biopharma (CUE) United States $0.079B 0.00
Elutia (ELUT) United States $0.079B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.077B 0.00
Aileron Therapeutics (ALRN) United States $0.076B 0.00
Atara Biotherapeutics (ATRA) United States $0.075B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.075B 0.00
Alpha Teknova (TKNO) United States $0.075B 0.00
Instil Bio (TIL) United States $0.072B 0.00
Bionano Genomics (BNGO) United States $0.072B 0.00
Genelux (GNLX) United States $0.071B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.070B 0.00
BioXcel Therapeutics (BTAI) United States $0.070B 0.00
Passage Bio (PASG) United States $0.070B 0.00
Intensity Therapeutics (INTS) United States $0.069B 0.00
Earth Science Tech (ETST) United States $0.068B 0.00
AVROBIO (AVRO) United States $0.068B 0.00
Lantern Pharma (LTRN) United States $0.067B 0.00
Celularity (CELU) United States $0.067B 0.00
Entera Bio (ENTX) Israel $0.067B 0.00
Curis (CRIS) United States $0.066B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.066B 0.00
MediciNova (MNOV) United States $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.065B 0.00
Rallybio (RLYB) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
Affimed (AFMD) Germany $0.064B 0.00
Leap Therapeutics (LPTX) United States $0.061B 0.00
AN2 Therapeutics (ANTX) United States $0.060B 0.00
Turnstone Biologics (TSBX) United States $0.060B 0.00
Genenta Science S.p.A (GNTA) Italy $0.060B 0.00
Immix Biopharma (IMMX) United States $0.059B 0.00
Theratechnologies (THTX) Canada $0.059B 0.00
LENZ Therapeutics (LENZ) United States $0.057B 0.00
Dyadic (DYAI) United States $0.057B 0.00
CalciMedica (CALC) United States $0.056B 0.00
China Health Industries Holdings (CHHE) China $0.056B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.055B 0.00
Cidara Therapeutics (CDTX) United States $0.055B 0.00
Enzo Biochem (ENZ) United States $0.055B 0.00
Carmell (CTCX) United States $0.053B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.053B 0.00
Kezar Life Sciences (KZR) United States $0.051B 0.00
Ocean Biomedical (OCEA) United States $0.051B 0.00
Equillium (EQ) United States $0.049B 0.00
ARCA Biopharma (ABIO) United States $0.049B 0.00
Ocuphire Pharma (OCUP) United States $0.046B 0.00
Kronos Bio (KRON) United States $0.045B 0.00
Aligos Therapeutics (ALGS) United States $0.045B 0.00
Aadi Bioscience (AADI) United States $0.045B 0.00
Clene (CLNN) United States $0.045B 0.00
IN8bio (INAB) United States $0.045B 0.00
Dare Bioscience (DARE) United States $0.044B 0.00
NextCure (NXTC) United States $0.043B 0.00
HCW Biologics (HCWB) United States $0.042B 0.00
Immuneering (IMRX) United States $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.040B 0.00
Beyond Air (XAIR) United States $0.040B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.040B 0.00
Xilio Therapeutics (XLO) United States $0.039B 0.00
Cyclo Therapeutics (CYTH) United States $0.039B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.038B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.037B 0.00
Fortress Biotech (FBIO) United States $0.037B 0.00
Quince Therapeutics (QNCX) United States $0.037B 0.00
Cara Therapeutics (CARA) United States $0.037B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
NKGen Biotech (NKGN) United States $0.035B 0.00
Evogene (EVGN) Israel $0.034B 0.00
MiNK Therapeutics (INKT) United States $0.033B 0.00
Promis Neurosciences (PMN) Canada $0.033B 0.00
Pluri (PLUR) Israel $0.032B 0.00
BioAffinity Technologies (BIAF) United States $0.031B 0.00
RenovoRx (RNXT) United States $0.030B 0.00
Bolt Biotherapeutics (BOLT) United States $0.030B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Femasys (FEMY) United States $0.028B 0.00
SAB Biotherapeutics (SABS) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
BRIACELL THERAP (BCTX) Canada $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Apollomics (APLM) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.021B 0.00
Forte Biosciences (FBRX) United States $0.021B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Lumos Pharma (LUMO) United States $0.020B 0.00
Sensei Biotherapeutics (SNSE) United States $0.020B 0.00
Purple Biotech (PPBT) Israel $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
VBI Vaccines (VBIV) United States $0.019B 0.00
KALA BIO (KALA) United States $0.018B 0.00
Aptose Biosciences (APTO) Canada $0.018B 0.00
Aytu BioPharma (AYTU) United States $0.018B 0.00
Galecto (GLTO) Denmark $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Senti Biosciences (SNTI) United States $0.016B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.015B 0.00
Imunon (IMNN) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Semper Paratus Acquisition (TVGN) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Elevai Labs (ELAB) United States $0.013B 0.00
Moleculin Biotech (MBRX) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.011B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
ABVC BioPharma (ABVC) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
BioCardia (BCDA) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
NuCana (NCNA) United Kingdom $0.009B 0.00
Kintara Therapeutics (KTRA) United States $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Vaccinex (VCNX) United States $0.009B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Trevena (TRVN) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Longeveron (LGVN) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Telesis Bio (TBIO) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
ThermoGenesis Holdings (THMO) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Alzamend Neuro (ALZN) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Virios Therapeutics (VIRI) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.43
TC BioPharm (Holdings) (TCBP) United Kingdom $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Seelos Therapeutics (SEEL) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.16
Mustang Bio (MBIO) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00